E213 - The PsychopharmaStahlogy Show: Is The ...

Originally released in 2021, this episode features Dr. Thomas Schwartz discussing common mistakes in psychopharmacology and how psychiatric clinicians can recognize and manage them. He explores diagnostic uncertainty, medication dosing, informed consent and monitoring, and ration ...  Show more

In this episode of PsychopharmaPearls, Dr. Andy Cutler and Dr. Will Sauvé discuss what clinicians need to know about kratom. They review why patients use it, signs of misuse, dependence, or withdrawal, and key pharmacologic and safety concerns. The conversation also offers practi ...  Show more

Send us Fan MailDoes using cannabis put you at a greater risk of developing schizophrenia? Is it safe to use psychedelic-assisted therapy for psychotic disorders? Is there a difference between the psychotic experience and the psychedelic experience?In today’s episode of the Psych ...  Show more

This might be the most "controversial" podcast episode I have ever done and I have never been more excited to talk about the science of psychedelics and the important studies being done right now to help people heal from trauma. We are talking about microdosing with the nations l ...  Show more

Magic mushrooms have hit the headlines, with people saying that shrooms cured their depression and anxiety. But is this for real? How can taking a trip on psychedelics fix your brain? Today, magic mushrooms ditch their tie dye for a lab coat as we go on a magical journey into the ...  Show more

In this episode, I discuss what psilocybin is (chemically) and how it works at the cellular and neural circuit level to trigger neuroplasticity, which is our brain’s ability to rewire itself in ways that lead to long-lasting shifts in our emotional, cognitive and behavioral patte ...  Show more